These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7065534)

  • 41. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1976 Nov; 2(7995):1102-4. PubMed ID: 62946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.
    Lancet; 1974 Aug; 2(7875):237-40. PubMed ID: 4135686
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.
    Banu Rekha VV; Rajaram K; Kripasankar AS; Parthasarathy R; Umapathy KC; Sheikh I; Selvakumar N; Victor M; Niruparani C; Sridhar R; Jawahar MS
    Natl Med J India; 2012; 25(4):196-200. PubMed ID: 23278775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Daily short course (6 months) chemotherapy for treatment of pulmonary tuberculosis in Nigerians: a preliminary report.
    Onadeko BO; Sofowora EO
    Afr J Med Med Sci; 1978 Sep; 7(3):175-81. PubMed ID: 108938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D; Radenbach D; Magnussen H
    Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B; Cramer G; Hamel U; Roth G
    Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
    Paramasivan CN; Chandrasekaran V; Santha T; Sudarsanam NM; Prabhakar R
    Tuber Lung Dis; 1993 Feb; 74(1):23-7. PubMed ID: 8495016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
    Mitchison DA; Nunn AJ
    Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
    Jindani A; Nunn AJ; Enarson DA
    Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.
    Babu Swai O; Aluoch JA; Githui WA; Thiong'o R; Edwards EA; Darbyshire JH; Nunn AJ
    Tubercle; 1988 Mar; 69(1):5-14. PubMed ID: 3051607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.